OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$891M
1-Year Return
19.89%
This Quarter Return
+8.53%
1 Year Return
+19.89%
3 Year Return
+77.46%
5 Year Return
–
10 Year Return
–
AUM
$1.1B
AUM Growth
+$245M
(+29%)
Cap. Flow
+$216M
Cap. Flow
% of AUM
19.55%
Top 10 Holdings %
Top 10 Hldgs %
8.02%
Holding
1,300
New
383
Increased
225
Reduced
257
Closed
427
Top Buys
| 1 |
Sherwin-Williams
SHW
|
+$9.11M |
| 2 |
Emerson Electric
EMR
|
+$8.96M |
| 3 |
CSX Corp
CSX
|
+$8.9M |
| 4 |
Exelon
EXC
|
+$8.89M |
| 5 |
Xcel Energy
XEL
|
+$8.87M |
Top Sells
| 1 |
Ferrari
RACE
|
+$3.89M |
| 2 |
Ecolab
ECL
|
+$3.74M |
| 3 |
The Mosaic Company
MOS
|
+$3.64M |
| 4 |
Ulta Beauty
ULTA
|
+$3.63M |
| 5 |
Marvell Technology
MRVL
|
+$3.63M |
Sector Composition
| 1 | Technology | 22.21% |
| 2 | Consumer Discretionary | 18.16% |
| 3 | Industrials | 16.18% |
| 4 | Consumer Staples | 8.59% |
| 5 | Financials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Cue Biopharma
CUE
$58.6M
| $46.9K | ﹤0.01% |
13,137
-1,519
| -10% | -$5.42K |
|
|
GAN
852
DELISTED
GAN Ltd
GAN
| $42.3K | ﹤0.01% |
32,764
+6,829
| +26% | +$8.81K |
|
853
Milestone Pharmaceuticals
MIST
$145M
| $41.2K | ﹤0.01% |
10,460
-28,668
| -73% | -$113K |
|
854
Precision BioSciences
DTIL
$59.1M
| $40.6K | ﹤0.01% |
1,794
-488
| -21% | -$11K |
|
855
Adverum Biotechnologies
ADVM
$69.5M
| $37.7K | ﹤0.01% |
5,256
-2,578
| -33% | -$18.5K |
|
|
PHLT
856
Performant Healthcare, Inc. Common Stock
PHLT
$604M
| $34.7K | ﹤0.01% |
+10,199
| New | +$34.7K |
|
857
Smith Micro Software
SMSI
$15.3M
| $34.1K | ﹤0.01% |
+3,677
| New | +$34.1K |
|
858
Barnes & Noble Education
BNED
$288M
| $33.6K | ﹤0.01% |
221
-36
| -14% | -$5.47K |
|
859
Praxis Precision Medicines
PRAX
$847M
| $33.4K | ﹤0.01% |
2,751
-163
| -6% | -$1.98K |
|
860
American Well
AMWL
$106M
| $32.3K | ﹤0.01% |
685
-18
| -3% | -$850 |
|
861
Quantum Corp
QMCO
$114M
| $31.4K | ﹤0.01% |
1,364
| – | – |
|
862
Absci
ABSI
$356M
| $29.3K | ﹤0.01% |
+16,717
| New | +$29.3K |
|
863
Aemetis
AMTX
$136M
| $29.1K | ﹤0.01% |
12,535
+2,040
| +19% | +$4.73K |
|
864
Passage Bio
PASG
$22.4M
| $26.6K | ﹤0.01% |
1,388
| – | – |
|
|
ATYR
865
aTyr Pharma
ATYR
$513M
| $25K | ﹤0.01% |
+11,922
| New | +$25K |
|
866
Ginkgo Bioworks
DNA
$609M
| $24.5K | ﹤0.01% |
+460
| New | +$24.5K |
|
867
American Resources Corp
AREC
$172M
| $23.9K | ﹤0.01% |
15,953
-72,423
| -82% | -$109K |
|
|
JOAN
868
DELISTED
JOANN, Inc. Common Stock
JOAN
| $22.2K | ﹤0.01% |
+13,991
| New | +$22.2K |
|
869
Inseego
INSG
$199M
| $21.4K | ﹤0.01% |
3,677
| – | – |
|
870
Vroom, Inc. Common Stock
VRM
$131M
| $13.1K | ﹤0.01% |
183
-2,657
| -94% | -$191K |
|
|
CYXT
871
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $12.4K | ﹤0.01% |
40,754
-72,876
| -64% | -$22.3K |
|
872
Bioventus
BVS
$468M
| $11.5K | ﹤0.01% |
10,739
-39,022
| -78% | -$41.8K |
|
873
Instil Bio
TIL
$155M
| $10.3K | ﹤0.01% |
780
-91
| -10% | -$1.2K |
|
|
KBAL
874
DELISTED
Kimball International
KBAL
| – | – |
-19,702
| Closed | -$128K |
|
|
TCRR
875
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – |
-32,803
| Closed | -$32.8K |
|